GapDB find and trade gaps by statistics
Biotech IBB+XBI 1Y Gap Scan
Updated 2023-04-01
click to sort
| Company | Symbol | TotalGap | FilledGap | UnfilledGap | UnfilledPct |
|---|---|---|---|---|---|
| Cullinan Oncology Inc | CGEM | 0 | 0 | 0 | 0.0 |
| Prometheus Biosciences Inc | RXDX | 4 | 3 | 1 | 25.0 |
| BeiGene Ltd - ADR | BGNE | 13 | 13 | 0 | 0.0 |
| Reata Pharmaceuticals Inc - Class A | RETA | 7 | 5 | 2 | 28.6 |
| Nektar Therapeutics | NKTR | 2 | 2 | 0 | 0.0 |
| Crinetics Pharmaceuticals Inc | CRNX | 2 | 2 | 0 | 0.0 |
| Pacific Biosciences of California Inc | PACB | 5 | 4 | 1 | 20.0 |
| Eiger BioPharmaceuticals Inc | EIGR | 2 | 2 | 0 | 0.0 |
| Morphic Holding Inc | MORF | 4 | 4 | 0 | 0.0 |
| Anavex Life Sciences Corporation | AVXL | 3 | 3 | 0 | 0.0 |
| Revance Therapeutics Inc | RVNC | 7 | 5 | 2 | 28.6 |
| Nurix Therapeutics Inc | NRIX | 3 | 3 | 0 | 0.0 |
| Akero Therapeutics Inc | AKRO | 2 | 0 | 2 | 100.0 |
| Precigen Inc | PGEN | 3 | 3 | 0 | 0.0 |
| Cymabay Therapeutics Inc | CBAY | 6 | 5 | 1 | 16.7 |
| Alnylam Pharmaceuticals Inc | ALNY | 4 | 3 | 1 | 25.0 |
| Nkarta Inc | NKTX | 6 | 6 | 0 | 0.0 |
| Allakos Inc | ALLK | 4 | 4 | 0 | 0.0 |
| Alaunos Therapeutics Inc | TCRT | 4 | 3 | 1 | 25.0 |
| Syndax Pharmaceuticals Inc | SNDX | 1 | 1 | 0 | 0.0 |
| Vertex Pharmaceuticals, Inc. | VRTX | 5 | 4 | 1 | 20.0 |
| Sangamo Therapeutics Inc | SGMO | 2 | 2 | 0 | 0.0 |
| Prelude Therapeutics Inc | PRLD | 2 | 2 | 0 | 0.0 |
| Replimune Group Inc | REPL | 4 | 4 | 0 | 0.0 |
| SpringWorks Therapeutics Inc | SWTX | 1 | 1 | 0 | 0.0 |
| Celldex Therapeutics Inc. | CLDX | 4 | 3 | 1 | 25.0 |
| Abbvie Inc | ABBV | 9 | 8 | 1 | 11.1 |
| Biomea Fusion Inc | BMEA | 4 | 1 | 3 | 75.0 |
| Emergent Biosolutions Inc | EBS | 7 | 6 | 1 | 14.3 |
| IGM Biosciences Inc | IGMS | 5 | 5 | 0 | 0.0 |
| Adaptimmune Therapeutics Plc - ADR | ADAP | 2 | 2 | 0 | 0.0 |
| Immunovant Inc | IMVT | 4 | 2 | 2 | 50.0 |
| Sutro Biopharma Inc | STRO | 2 | 2 | 0 | 0.0 |
| Scilex Holding Company | SCLX | 3 | 2 | 1 | 33.3 |
| Ventyx Biosciences Inc | VTYX | 4 | 1 | 3 | 75.0 |
| Protagonist Therapeutics Inc | PTGX | 3 | 2 | 1 | 33.3 |
| Arvinas Inc | ARVN | 6 | 6 | 0 | 0.0 |
| Intra-Cellular Therapies Inc | ITCI | 4 | 2 | 2 | 50.0 |
| POINT Biopharma Global Inc | PNT | 4 | 4 | 0 | 0.0 |
| Natera Inc | NTRA | 7 | 6 | 1 | 14.3 |
| Nautilus Biotechnology Inc | NAUT | 1 | 1 | 0 | 0.0 |
| Repare Therapeutics Inc | RPTX | 4 | 4 | 0 | 0.0 |
| Verve Therapeutics Inc | VERV | 2 | 2 | 0 | 0.0 |
| Monte Rosa Therapeutics Inc | GLUE | 0 | 0 | 0 | 0.0 |
| Atea Pharmaceuticals Inc | AVIR | 1 | 1 | 0 | 0.0 |
| Wave Life Sciences Ltd. | WVE | 4 | 3 | 1 | 25.0 |
| Aclaris Therapeutics Inc | ACRS | 2 | 2 | 0 | 0.0 |
| Ionis Pharmaceuticals Inc | IONS | 5 | 5 | 0 | 0.0 |
| Twist Bioscience Corp | TWST | 9 | 9 | 0 | 0.0 |
| Arrowhead Pharmaceuticals Inc. | ARWR | 2 | 2 | 0 | 0.0 |
| Day One Biopharmaceuticals Inc | DAWN | 3 | 2 | 1 | 33.3 |
| Mettler-Toledo International, Inc. | MTD | 12 | 10 | 2 | 16.7 |
| Blueprint Medicines Corp | BPMC | 6 | 6 | 0 | 0.0 |
| Mimedx Group Inc | MDXG | 1 | 1 | 0 | 0.0 |
| Arbutus Biopharma Corp | ABUS | 1 | 1 | 0 | 0.0 |
| Kura Oncology Inc | KURA | 2 | 1 | 1 | 50.0 |
| DBV Technologies - ADR | DBVT | 17 | 15 | 2 | 11.8 |
| Scholar Rock Holding Corp | SRRK | 4 | 4 | 0 | 0.0 |
| Avid Bioservices Inc | CDMO | 5 | 4 | 1 | 20.0 |
| Galapagos NV - ADR | GLPG | 21 | 20 | 1 | 4.8 |
| Kezar Life Sciences Inc | KZR | 4 | 4 | 0 | 0.0 |
| Keros Therapeutics Inc | KROS | 3 | 2 | 1 | 33.3 |
| Biomarin Pharmaceutical Inc. - Registered Shares | BMRN | 7 | 6 | 1 | 14.3 |
| Inhibrx Inc | INBX | 4 | 3 | 1 | 25.0 |
| Cytek BioSciences Inc | CTKB | 1 | 1 | 0 | 0.0 |
| Anika Therapeutics Inc. | ANIK | 1 | 1 | 0 | 0.0 |
| Charles River Laboratories International Inc. | CRL | 10 | 10 | 0 | 0.0 |
| CureVac N.V. | CVAC | 5 | 5 | 0 | 0.0 |
| Viridian Therapeutics Inc | VRDN | 5 | 3 | 2 | 40.0 |
| Akoya Biosciences Inc | AKYA | 2 | 2 | 0 | 0.0 |
| BioAtla Inc | BCAB | 3 | 3 | 0 | 0.0 |
| AnaptysBio Inc | ANAB | 3 | 3 | 0 | 0.0 |
| Genmab - ADR | GMAB | 24 | 19 | 5 | 20.8 |
| Arcutis Biotherapeutics Inc | ARQT | 4 | 4 | 0 | 0.0 |
| Axsome Therapeutics Inc | AXSM | 6 | 4 | 2 | 33.3 |
| Adicet Bio Inc | ACET | 3 | 3 | 0 | 0.0 |
| Arcellx Inc | ACLX | 7 | 4 | 3 | 42.9 |
| Grifols SA - ADR - Level III | GRFS | 14 | 12 | 2 | 14.3 |
| Verona Pharma Plc - ADR | VRNA | 2 | 0 | 2 | 100.0 |
| Exact Sciences Corp. | EXAS | 11 | 8 | 3 | 27.3 |
| Caredx Inc | CDNA | 5 | 5 | 0 | 0.0 |
| Biohaven Ltd | BHVN | 1 | 1 | 0 | 0.0 |
| Moderna Inc | MRNA | 10 | 10 | 0 | 0.0 |
| Alx Oncology Holdings Inc | ALXO | 2 | 2 | 0 | 0.0 |
| Zai Lab Limited - ADR | ZLAB | 12 | 11 | 1 | 8.3 |
| RAPT Therapeutics Inc | RAPT | 3 | 3 | 0 | 0.0 |
| Amicus Therapeutics Inc | FOLD | 3 | 2 | 1 | 33.3 |
| Roivant Sciences Ltd | ROIV | 1 | 0 | 1 | 100.0 |
| Sarepta Therapeutics Inc | SRPT | 6 | 4 | 2 | 33.3 |
| BioNTech SE - ADR | BNTX | 7 | 7 | 0 | 0.0 |
| Omega Therapeutics Inc | OMGA | 1 | 1 | 0 | 0.0 |
| Zentalis Pharmaceuticals Inc | ZNTL | 3 | 3 | 0 | 0.0 |
| EQRx Inc | EQRX | 4 | 4 | 0 | 0.0 |
| Revolution Medicines Inc | RVMD | 2 | 2 | 0 | 0.0 |
| Lineage Cell Therapeutics Inc | LCTX | 2 | 2 | 0 | 0.0 |
| Alkermes plc | ALKS | 3 | 2 | 1 | 33.3 |
| Biocryst Pharmaceuticals Inc. | BCRX | 3 | 3 | 0 | 0.0 |
| Kodiak Sciences Inc | KOD | 7 | 7 | 0 | 0.0 |
| Kymera Therapeutics Inc | KYMR | 5 | 4 | 1 | 20.0 |
| Tarsus Pharmaceuticals Inc | TARS | 0 | 0 | 0 | 0.0 |
| Medpace Holdings Inc | MEDP | 13 | 12 | 1 | 7.7 |
| Illumina Inc | ILMN | 10 | 8 | 2 | 20.0 |
| ARS Pharmaceuticals Inc | SPRY | 1 | 1 | 0 | 0.0 |
| Regeneron Pharmaceuticals, Inc. | REGN | 5 | 2 | 3 | 60.0 |
| Poseida Therapeutics Inc | PSTX | 4 | 3 | 1 | 25.0 |
| Syneos Health Inc - Class A | SYNH | 10 | 9 | 1 | 10.0 |
| Arcus Biosciences Inc | RCUS | 6 | 6 | 0 | 0.0 |
| FibroGen Inc | FGEN | 6 | 5 | 1 | 16.7 |
| Ascendis Pharma A/S - ADR | ASND | 1 | 1 | 0 | 0.0 |
| Macrogenics Inc | MGNX | 4 | 4 | 0 | 0.0 |
| Gossamer Bio Inc | GOSS | 3 | 3 | 0 | 0.0 |
| Neurocrine Biosciences, Inc. | NBIX | 4 | 3 | 1 | 25.0 |
| Ngm Biopharmaceuticals Inc | NGM | 2 | 2 | 0 | 0.0 |
| Altimmune Inc | ALT | 3 | 3 | 0 | 0.0 |
| Graphite Bio Inc | GRPH | 3 | 2 | 1 | 33.3 |
| Alector Inc | ALEC | 4 | 4 | 0 | 0.0 |
| Abcam - ADR (Sponsored) | ABCM | 18 | 18 | 0 | 0.0 |
| I-Mab - ADR | IMAB | 3 | 3 | 0 | 0.0 |
| Cara Therapeutics Inc | CARA | 2 | 2 | 0 | 0.0 |
| Adma Biologics Inc | ADMA | 3 | 2 | 1 | 33.3 |
| Century Therapeutics Inc | IPSC | 0 | 0 | 0 | 0.0 |
| Vir Biotechnology Inc | VIR | 5 | 5 | 0 | 0.0 |
| Cerevel Therapeutics Holdings Inc | CERE | 4 | 4 | 0 | 0.0 |
| Absci Corp | ABSI | 1 | 1 | 0 | 0.0 |
| Instil Bio Inc | TIL | 2 | 2 | 0 | 0.0 |
| Repligen Corp. | RGEN | 12 | 11 | 1 | 8.3 |
| Exscientia Plc - ADR | EXAI | 4 | 4 | 0 | 0.0 |
| Cogent Biosciences Inc | COGT | 4 | 3 | 1 | 25.0 |
| Voyager Therapeutics Inc | VYGR | 1 | 0 | 1 | 100.0 |
| 89bio Inc | ETNB | 4 | 2 | 2 | 50.0 |
| Intellia Therapeutics Inc | NTLA | 8 | 8 | 0 | 0.0 |
| Bruker Corp | BRKR | 5 | 5 | 0 | 0.0 |
| MeiraGTx Holdings plc | MGTX | 1 | 1 | 0 | 0.0 |
| BioXcel Therapeutics Inc | BTAI | 3 | 1 | 2 | 66.7 |
| 2seventy bio Inc | TSVT | 2 | 2 | 0 | 0.0 |
| Summit Therapeutics Inc | SMMT | 2 | 1 | 1 | 50.0 |
| CTI BioPharma Corp | CTIC | 2 | 1 | 1 | 50.0 |
| Stoke Therapeutics Inc | STOK | 5 | 5 | 0 | 0.0 |
| Beam Therapeutics Inc | BEAM | 4 | 4 | 0 | 0.0 |
| Madrigal Pharmaceuticals Inc | MDGL | 5 | 4 | 1 | 20.0 |
| AMGEN Inc. | AMGN | 7 | 7 | 0 | 0.0 |
| Fulgent Genetics Inc | FLGT | 4 | 4 | 0 | 0.0 |
| Foghorn Therapeutics Inc | FHTX | 1 | 1 | 0 | 0.0 |
| Gritstone Bio Inc | GRTS | 2 | 1 | 1 | 50.0 |
| Kiniksa Pharmaceuticals Ltd - Class A | KNSA | 6 | 6 | 0 | 0.0 |
| Immunogen, Inc. | IMGN | 3 | 2 | 1 | 33.3 |
| Waters Corp. | WAT | 18 | 16 | 2 | 11.1 |
| Nanostring Technologies Inc | NSTG | 9 | 8 | 1 | 11.1 |
| Caribou Biosciences Inc | CRBU | 2 | 2 | 0 | 0.0 |
| G1 Therapeutics Inc | GTHX | 3 | 3 | 0 | 0.0 |
| Olink Holding AB (publ) - ADR | OLK | 2 | 2 | 0 | 0.0 |
| Dynavax Technologies Corp. | DVAX | 3 | 2 | 1 | 33.3 |
| Horizon Therapeutics Plc | HZNP | 5 | 1 | 4 | 80.0 |
| Vaxcyte Inc | PCVX | 2 | 0 | 2 | 100.0 |
| Avidity Biosciences Inc | RNA | 3 | 2 | 1 | 33.3 |
| Kinnate Biopharma Inc | KNTE | 2 | 2 | 0 | 0.0 |
| United Therapeutics Corp | UTHR | 2 | 2 | 0 | 0.0 |
| Marinus Pharmaceuticals Inc | MRNS | 3 | 1 | 2 | 66.7 |
| Catalyst Pharmaceuticals Inc | CPRX | 5 | 3 | 2 | 40.0 |
| Maravai LifeSciences Holdings Inc - Class A | MRVI | 6 | 6 | 0 | 0.0 |
| Lyell Immunopharma Inc | LYEL | 0 | 0 | 0 | 0.0 |
| Insmed Inc | INSM | 5 | 5 | 0 | 0.0 |
| IQVIA Holdings Inc | IQV | 13 | 11 | 2 | 15.4 |
| Stevanato Group Spa | STVN | 1 | 1 | 0 | 0.0 |
| Terns Pharmaceuticals Inc | TERN | 6 | 3 | 3 | 50.0 |
| Halozyme Therapeutics Inc. | HALO | 2 | 2 | 0 | 0.0 |
| Aurinia Pharmaceuticals Inc | AUPH | 5 | 3 | 2 | 40.0 |
| Allogene Therapeutics Inc | ALLO | 3 | 3 | 0 | 0.0 |
| Annexon Inc | ANNX | 7 | 5 | 2 | 28.6 |
| MaxCyte Inc | MXCT | 2 | 1 | 1 | 50.0 |
| ITeos Therapeutics Inc | ITOS | 2 | 2 | 0 | 0.0 |
| Seres Therapeutics Inc | MCRB | 0 | 0 | 0 | 0.0 |
| Gracell Biotechnologies Inc - ADR | GRCL | 1 | 1 | 0 | 0.0 |
| Quanterix Corp | QTRX | 7 | 7 | 0 | 0.0 |
| Legend Biotech Corp - ADR | LEGN | 5 | 3 | 2 | 40.0 |
| Prothena Corporation plc | PRTA | 5 | 4 | 1 | 20.0 |
| BridgeBio Pharma Inc | BBIO | 4 | 3 | 1 | 25.0 |
| Exelixis Inc | EXEL | 6 | 5 | 1 | 16.7 |
| Denali Therapeutics Inc | DNLI | 4 | 4 | 0 | 0.0 |
| Mirati Therapeutics Inc | MRTX | 6 | 6 | 0 | 0.0 |
| Humacyte Inc | HUMA | 2 | 2 | 0 | 0.0 |
| Bluebird bio Inc | BLUE | 3 | 3 | 0 | 0.0 |
| Immuneering Corp Class A | IMRX | 1 | 1 | 0 | 0.0 |
| Bicycle Therapeutics Plc - ADR | BCYC | 1 | 1 | 0 | 0.0 |
| Adc Therapeutics SA | ADCT | 3 | 3 | 0 | 0.0 |
| Pliant Therapeutics Inc | PLRX | 4 | 1 | 3 | 75.0 |
| Fate Therapeutics Inc | FATE | 2 | 2 | 0 | 0.0 |
| ImmunityBio Inc | IBRX | 2 | 2 | 0 | 0.0 |
| Sana Biotechnology Inc | SANA | 3 | 3 | 0 | 0.0 |
| Agenus Inc | AGEN | 1 | 1 | 0 | 0.0 |
| Chinook Therapeutics Inc | KDNY | 5 | 4 | 1 | 20.0 |
| Atara Biotherapeutics Inc | ATRA | 1 | 1 | 0 | 0.0 |
| Rocket Pharmaceuticals Inc | RCKT | 5 | 3 | 2 | 40.0 |
| Xencor Inc | XNCR | 3 | 2 | 1 | 33.3 |
| Seagen Inc | SGEN | 7 | 3 | 4 | 57.1 |
| UroGen Pharma Ltd | URGN | 3 | 3 | 0 | 0.0 |
| Mannkind Corp | MNKD | 1 | 1 | 0 | 0.0 |
| uniQure N.V. | QURE | 8 | 6 | 2 | 25.0 |
| Edgewise Therapeutics Inc | EWTX | 4 | 4 | 0 | 0.0 |
| Mirum Pharmaceuticals Inc | MIRM | 3 | 3 | 0 | 0.0 |
| Codexis Inc. | CDXS | 6 | 6 | 0 | 0.0 |
| Amylyx Pharmaceuticals Inc | AMLX | 3 | 1 | 2 | 66.7 |
| Arcturus Therapeutics Holdings Inc | ARCT | 5 | 4 | 1 | 20.0 |
| C4 Therapeutics Inc | CCCC | 2 | 2 | 0 | 0.0 |
| Biogen Inc | BIIB | 5 | 4 | 1 | 20.0 |
| Adaptive Biotechnologies Corp | ADPT | 11 | 11 | 0 | 0.0 |
| Ardelyx Inc | ARDX | 4 | 2 | 2 | 50.0 |
| AbCellera Biologics Inc | ABCL | 6 | 5 | 1 | 16.7 |
| Acumen Pharmaceuticals Inc | ABOS | 1 | 1 | 0 | 0.0 |
| Viking Therapeutics Inc | VKTX | 3 | 1 | 2 | 66.7 |
| Myriad Genetics, Inc. | MYGN | 7 | 5 | 2 | 28.6 |
| Relay Therapeutics Inc | RLAY | 3 | 3 | 0 | 0.0 |
| Iovance Biotherapeutics Inc | IOVA | 7 | 6 | 1 | 14.3 |
| Vanda Pharmaceuticals Inc | VNDA | 2 | 2 | 0 | 0.0 |
| Incyte Corp. | INCY | 4 | 4 | 0 | 0.0 |
| Invivyd Inc | IVVD | 2 | 2 | 0 | 0.0 |
| Editas Medicine Inc | EDIT | 4 | 4 | 0 | 0.0 |
| CRISPR Therapeutics AG | CRSP | 8 | 8 | 0 | 0.0 |
| Phathom Pharmaceuticals Inc | PHAT | 5 | 5 | 0 | 0.0 |
| Nuvalent Inc - Class A | NUVL | 4 | 2 | 2 | 50.0 |
| Ginkgo Bioworks Holdings Inc - Class A | DNA | 2 | 2 | 0 | 0.0 |
| AlloVir Inc | ALVR | 6 | 6 | 0 | 0.0 |
| Sage Therapeutics Inc | SAGE | 1 | 1 | 0 | 0.0 |
| Invitae Corp | NVTA | 3 | 3 | 0 | 0.0 |
| Travere Therapeutics Inc | TVTX | 4 | 4 | 0 | 0.0 |
| PMV Pharmaceuticals Inc | PMVP | 3 | 3 | 0 | 0.0 |
| Seer Inc - Class A | SEER | 6 | 6 | 0 | 0.0 |
| Tango Therapeutics Inc | TNGX | 4 | 4 | 0 | 0.0 |
| Vericel Corp | VCEL | 4 | 4 | 0 | 0.0 |
| Bellus Health Inc | BLU | 2 | 2 | 0 | 0.0 |
| Recursion Pharmaceuticals Inc - Class A | RXRX | 4 | 4 | 0 | 0.0 |
| Zymeworks BC Inc | ZYME | 4 | 2 | 2 | 50.0 |
| Selecta Biosciences Inc | SELB | 4 | 3 | 1 | 25.0 |
| Acadia Pharmaceuticals Inc | ACAD | 5 | 5 | 0 | 0.0 |
| Deciphera Pharmaceuticals Inc | DCPH | 2 | 2 | 0 | 0.0 |
| Cytokinetics Inc | CYTK | 0 | 0 | 0 | 0.0 |
| Karuna Therapeutics Inc | KRTX | 1 | 0 | 1 | 100.0 |
| Erasca Inc | ERAS | 1 | 1 | 0 | 0.0 |
| Generation Bio Co | GBIO | 3 | 2 | 1 | 33.3 |
| Bio-Techne Corp | TECH | 8 | 8 | 0 | 0.0 |
| Geron Corp. | GERN | 1 | 1 | 0 | 0.0 |
| 10x Genomics Inc - Class A | TXG | 8 | 7 | 1 | 12.5 |
| Merus N.V | MRUS | 0 | 0 | 0 | 0.0 |
| Immunocore Holdings plc - ADR | IMCR | 1 | 0 | 1 | 100.0 |
| Ultragenyx Pharmaceutical Inc. | RARE | 6 | 6 | 0 | 0.0 |
| Theravance Biopharma Inc | TBPH | 3 | 3 | 0 | 0.0 |
| Nuvation Bio Inc - Class A | NUVB | 0 | 0 | 0 | 0.0 |
| Opko Health Inc | OPK | 0 | 0 | 0 | 0.0 |
| Ideaya Biosciences Inc | IDYA | 3 | 2 | 1 | 33.3 |
| Provention Bio Inc | PRVB | 8 | 5 | 3 | 37.5 |
| Affimed N.V. | AFMD | 3 | 3 | 0 | 0.0 |
| Regenxbio Inc | RGNX | 7 | 7 | 0 | 0.0 |
| Coherus Biosciences Inc | CHRS | 1 | 0 | 1 | 100.0 |
| Gilead Sciences, Inc. | GILD | 11 | 5 | 6 | 54.5 |
| Novavax, Inc. | NVAX | 2 | 2 | 0 | 0.0 |
| Agios Pharmaceuticals Inc | AGIO | 4 | 3 | 1 | 25.0 |
| Krystal Biotech Inc | KRYS | 7 | 5 | 2 | 28.6 |
| DICE Therapeutics Inc | DICE | 2 | 1 | 1 | 50.0 |
| PTC Therapeutics Inc | PTCT | 3 | 2 | 1 | 33.3 |
| ATAI Life Sciences N.V. | ATAI | 6 | 5 | 1 | 16.7 |
| Intercept Pharmaceuticals Inc | ICPT | 3 | 3 | 0 | 0.0 |
| Apellis Pharmaceuticals Inc | APLS | 5 | 2 | 3 | 60.0 |
| Actinium Pharmaceuticals Inc | ATNM | 3 | 2 | 1 | 33.3 |
| Alpine Immune Sciences Inc | ALPN | 6 | 6 | 0 | 0.0 |
| Fulcrum Therapeutics Inc | FULC | 1 | 1 | 0 | 0.0 |
| Rhythm Pharmaceuticals Inc. | RYTM | 2 | 2 | 0 | 0.0 |
| Mersana Therapeutics Inc | MRSN | 6 | 5 | 1 | 16.7 |
| NovoCure Ltd | NVCR | 5 | 5 | 0 | 0.0 |
| Veracyte Inc | VCYT | 7 | 6 | 1 | 14.3 |
| Ironwood Pharmaceuticals Inc - Class A | IRWD | 1 | 1 | 0 | 0.0 |
| TG Therapeutics Inc | TGTX | 5 | 3 | 2 | 40.0 |
| 4D Molecular Therapeutics Inc | FDMT | 3 | 2 | 1 | 33.3 |
| Compass Pathways Plc - ADR | CMPS | 3 | 3 | 0 | 0.0 |
| Design Therapeutics Inc | DSGN | 2 | 2 | 0 | 0.0 |
| Dyne Therapeutics Inc | DYN | 1 | 1 | 0 | 0.0 |
| PepGen Inc | PEPG | 5 | 4 | 1 | 20.0 |
| GreenLight Biosciences Inc | GRNA | 1 | 1 | 0 | 0.0 |
| Evelo Biosciences Inc | EVLO | 0 | 0 | 0 | 0.0 |
| Enanta Pharmaceuticals Inc | ENTA | 1 | 1 | 0 | 0.0 |
| Autolus Therapeutics plc - ADR | AUTL | 1 | 1 | 0 | 0.0 |
| Xenon Pharmaceuticals Inc | XENE | 6 | 6 | 0 | 0.0 |
| Castle Biosciences Inc | CSTL | 6 | 5 | 1 | 16.7 |
| Argen X SE - ADR | ARGX | 8 | 7 | 1 | 12.5 |
| Inovio Pharmaceuticals Inc | INO | 2 | 2 | 0 | 0.0 |
| Ligand Pharmaceuticals, Inc. - Class B | LGND | 11 | 11 | 0 | 0.0 |
| Centessa Pharmaceuticals plc - ADR | CNTA | 3 | 3 | 0 | 0.0 |
| IVERIC bio Inc | ISEE | 8 | 5 | 3 | 37.5 |
| Karyopharm Therapeutics Inc | KPTI | 3 | 3 | 0 | 0.0 |
Gap Statistics:
Must-Read Books on Technical Analysis:
Japanese Candlestick Charting Techniques by Steve Nison
Technical Analysis of the Financial Markets by John Murphy
